Raymond Brig
Hematology & Oncology · Knoxville, TNNPI 1588664627
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,326 of the $4,684 with a category attached, or 71.0%. 31 manufacturers reported payments, led by Radius Health, Inc. at 40.3% of the total. Reporting peaked in 2019 at $4,233 and has fallen 99.7% since, to $12 in 2021. That places this record below the midpoint for hematology & oncology clinicians in TN, where the typical reported total is $5,575.
Across 150 payments — averaging $31.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Radius Health, Inc.$2K
- Genentech USA, Inc.$392
- Novartis$362
- Amgen$329
- Bristol Myers Squibb$163
- AstraZeneca$162
- plus $1K from 25 others
Across 113 payments — averaging $4977.44 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$215K
- Radius Health, Inc.$152K
- Daiichi Sankyo Inc.$103K
- Pfizer$60K
- Amgen$15K
- Astrazeneca UK Limited$15K
- plus $2K from 1 others
What the payments were for
- Travel & lodging$1,33629%
- Food & beverage$3,32671%
- Education$220%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Radius Health, Inc. | 8 | $1,886 |
| Genentech USA, Inc. | 22 | $392 |
| Novartis | 19 | $362 |
| Amgen | 14 | $329 |
| Bristol Myers Squibb | 4 | $163 |
| AstraZeneca | 8 | $162 |
| Lilly USA, LLC | 6 | $155 |
| Merck | 4 | $139 |
| Pfizer | 11 | $111 |
| ASD Specialty Healthcare, LLC | 1 | $103 |
| Seagen Inc. | 7 | $97 |
| Puma Biotechnology, Inc. | 7 | $95 |
| Daiichi Sankyo Inc. | 5 | $84 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $84 |
| Eisai Inc. | 3 | $70 |
| Elekta, Inc. | 1 | $70 |
| Helsinn Therapeutics (U.S.), Inc. | 3 | $49 |
| Mylan Institutional Inc. | 3 | $45 |
| Ipsen Biopharmaceuticals, Inc | 2 | $34 |
| Johnson & Johnson | 2 | $30 |
| Gilead | 2 | $29 |
| Heron Therapeutics, Inc. | 1 | $28 |
| Incyte Corporation | 2 | $28 |
| Zyla Life Sciences, Inc. | 2 | $26 |
| EMD Serono, Inc. | 2 | $25 |
| Rigel Pharmaceuticals, Inc. | 1 | $19 |
| Bayer | 1 | $18 |
| E.r. Squibb & Sons, L.L.C. | 1 | $16 |
| Fortovia Therapeutics, Inc. | 1 | $13 |
| Array Biopharma Inc | 1 | $13 |
| Taiho Oncology, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,684 in reported general payments places this provider in the 45th percentile of 251 hematology & oncology providers in Tennessee.
Other hematology & oncology in Knoxville
- Daniel IbachKnoxville$36K
- Ross KernsKnoxville$34K
- Arun KumarKnoxville$31K
- Nathan SchrockKnoxville$28K
- Sudarshan DoddabeleKnoxville$23K
- Jonathan AbbasNashville$1.3M
- Alan TanNashville$1.1M
- Kent ShihNashville$900K
- Jason PorterGermantown$756K
- Brian RiniNashville$601K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.